Clinical Trial

Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma

Name: Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma — clinical trial record (NCT06416930)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a multicenter, single-arm, phase II clinical study to evaluate the safety and efficacy of Cadonilimab combined with gemcitabine, or vinorelbine, or pemetrexed in the treatment of patients with recurrent / refractory pleural mesothelioma.

Trial Details

NCT Number	NCT06416930
Lead Sponsor	Cancer Institute and Hospital, Chinese Academy of Medical Sciences Collaborators: Akesobio
Conditions	Pleural Mesothelioma
Enrollment	59 participants
Start Date	2024-06-20
Primary Completion	2027-06-20 (estimated)
Study Completion	2029-06-20 (estimated)
Updated on ClinicalTrials.gov	2024-05-16